A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
Conditions: Sarcoma, Ewing; Chondrosarcoma; Osteosarcoma; Fibrous Histiocytoma; Fibrosarcoma Interventions: Device: 3D Printed Anatomic Model; Diagnostic Test: CT/MRI Sponsors: Ricoh USA, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors
Conditions: Metastatic Chondrosarcoma; Locally Advanced Chondrosarcoma; Metastatic Sinonasal Adenocarcinoma; Locally Advanced Sinonasal Adenocarcinoma; Metastatic Large-cell Neuroendocrine Carcinoma; Locally Advanced Large-cell Neuroendocrine Carcinoma; Metastatic Olfactory Neuroblastoma; Locally Advanced Olfactory Neuroblastoma; Metastatic Sinonasal Undifferentiated Carcinoma; Locally Advanced Sinonasal Undifferentiated Carcinoma Interventions: Drug: Enasidenib Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Conditions: Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen Interventions: Drug: Ivosidenib 500mg; Drug: Placebo Sponsors: Servier Bio-Innovation LLC; Institut de Recherches Internationales Servier Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Conditions: Chordoma; Chondrosarcoma; Ewing Sarcoma; Osteosarcoma Interventions: Radiation: Proteus ONE one daily beam; Radiation: Proteus ONE two daily beam Sponsor: Centre Antoine Lacassagne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Understanding Engagement Trends in Chondrosarcoma Clinical Trials
Condition: Chondrosarcoma Intervention: Sponsor: Power Life Sciences Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Conditions: Chordoma; Chondrosarcoma; Ewing Sarcoma; Osteosarcoma Interventions: Radiation: Proteus ONE one daily beam; Radiation: Proteus ONE two daily beam Sponsor: Centre Antoine Lacassagne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Understanding Engagement Trends in Chondrosarcoma Clinical Trials
Condition: Chondrosarcoma Intervention: Sponsor: Power Life Sciences Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Conditions: Chordoma; Chondrosarcoma; Ewing Sarcoma; Osteosarcoma Interventions: Radiation: Proteus ONE one daily beam; Radiation: Proteus ONE two daily beam Sponsor: Centre Antoine Lacassagne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Understanding Engagement Trends in Chondrosarcoma Clinical Trials
Condition: Chondrosarcoma Intervention: Sponsor: Power Life Sciences Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Conditions: Chordoma; Chondrosarcoma; Ewing Sarcoma; Osteosarcoma Interventions: Radiation: Proteus ONE one daily beam; Radiation: Proteus ONE two daily beam Sponsor: Centre Antoine Lacassagne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Understanding Engagement Trends in Chondrosarcoma Clinical Trials
Condition: Chondrosarcoma Intervention: Sponsor: Power Life Sciences Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
Conditions: Chordoma; Chondrosarcoma; Ewing Sarcoma; Osteosarcoma Interventions: Radiation: Proteus ONE one daily beam; Radiation: Proteus ONE two daily beam Sponsor: Centre Antoine Lacassagne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
Understanding Engagement Trends in Chondrosarcoma Clinical Trials
Condition: Chondrosarcoma Intervention: Sponsor: Power Life Sciences Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials
